BJDX (Bluejay Diagnostics, Inc. Common Stock) Stock Analysis - Politician Trades
Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of May 21, 2026, BJDX trades at $1.79 with a market cap of $1.78M and a P/E ratio of -0.11. BJDX moved +0.00% today. Year to date, BJDX is -32.95%; over the trailing twelve months it is -76.73%. Its 52-week range spans $1.62 to $49.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded BJDX stock?
Rallies tracks politician and congressional stock disclosures for BJDX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Wurth Douglas Clark bought 12.50K (~$25.00K) on Mar 14, 2026.
Dey Indranil bought 12.50K (~$25.00K) on Mar 14, 2026.
CHASE DONALD R bought 12.50K (~$25.00K) on Mar 14, 2026.
BJDX Analyst Consensus
BJDX analyst coverage data. Average price target: $0.00.
Common questions about BJDX
Which politicians traded BJDX stock?
Rallies tracks politician and congressional stock disclosures for BJDX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in BJDX?
Yes. Rallies tracks politician and congressional stock disclosures for BJDX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BJDX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.